Immuneering Corporation (IMRX) Misses Q4 EPS by 13c
Tweet
Share
E-mail
Get Alerts IMRX Hot Sheet
Join SI Premium – FREE
Immuneering Corporation (NASDAQ: IMRX) reported Q4 EPS of ($0.58), $0.13 worse than the analyst estimate of ($0.45).
For earnings history and earnings-related data on Immuneering Corporation (IMRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Dell shares surge on record AI server bookings
- Dell Technologies (DELL) call put ratio 1.1 calls to 1 put as share price up 11%
- DA Davidson Reiterates Buy Rating on Oracle (ORCL) Following Q1 Print
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
